Mucocutaneous Lymph Node Syndrome

"Mucocutaneous Lymph Node Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.

Descriptor ID	D009080
MeSH Number(s)	C14.907.940.560 C15.604.560 C17.800.862.560
Concept/Terms	Mucocutaneous Lymph Node Syndrome Mucocutaneous Lymph Node Syndrome Kawasaki Syndrome Lymph Node Syndrome, Mucocutaneous Kawasaki Disease

Below are MeSH descriptors whose meaning is more general than "Mucocutaneous Lymph Node Syndrome".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Vasculitis [C14.907.940]
Mucocutaneous Lymph Node Syndrome [C14.907.940.560]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Mucocutaneous Lymph Node Syndrome [C15.604.560]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Skin Diseases, Vascular [C17.800.862]
Mucocutaneous Lymph Node Syndrome [C17.800.862.560]

Below are MeSH descriptors whose meaning is related to "Mucocutaneous Lymph Node Syndrome".

Below are MeSH descriptors whose meaning is more specific than "Mucocutaneous Lymph Node Syndrome".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mucocutaneous Lymph Node Syndrome" by people in this website by year, and whether "Mucocutaneous Lymph Node Syndrome" was a major or minor topic of these publications.

Bar chart showing 8 publications over 8 distinct years, with a maximum of 1 publications in 1994 and 2001 and 2002 and 2006 and 2007 and 2012 and 2020 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
2001	0	1	1
2002	1	0	1
2006	0	1	1
2007	0	1	1
2012	0	1	1
2020	0	1	1
2021	1	0	1

Below are the most recent publications written about "Mucocutaneous Lymph Node Syndrome" by people in Profiles.

Christ A, Latz E. Deciphering How NLRP3 Incites the Stromal Response in Kawasaki Vasculitis. Circ Res. 2021 10 15; 129(9):840-842.

View in: PubMed
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA, Singh AR, Li S, Tarquinio KM, Jaggi P, Oster ME, Zackai SP, Gillen J, Ratner AJ, Walsh RF, Fitzgerald JC, Keenaghan MA, Alharash H, Doymaz S, Clouser KN, Giuliano JS, Gupta A, Parker RM, Maddux AB, Havalad V, Ramsingh S, Bukulmez H, Bradford TT, Smith LS, Tenforde MW, Carroll CL, Riggs BJ, Gertz SJ, Daube A, Lansell A, Coronado Munoz A, Hobbs CV, Marohn KL, Halasa NB, Patel MM, Randolph AG. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020 07 23; 383(4):334-346.

View in: PubMed
Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, Head SR, Burns JC, Rana TM. The long noncoding RNA THRIL regulates TNFa expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A. 2014 Jan 21; 111(3):1002-7.

View in: PubMed
McQueen A, Martin SA, Lio PA. Derm emergencies: detecting early signs of trouble. J Fam Pract. 2012 Feb; 61(2):71-8.

View in: PubMed
Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. J Cardiovasc Nurs. 2007 May-Jun; 22(3):218-53.

View in: PubMed
Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006 Dec 12; 114(24):2710-38.

View in: PubMed
Israels SJ, Michelson AD. Antiplatelet therapy in children. Thromb Res. 2006; 118(1):75-83.

View in: PubMed
Schratz LM, Meyer RA, Schwartz DC. Serial intracoronary ultrasound in children: feasibility, reproducibility, limitations, and safety. J Am Soc Echocardiogr. 2002 Aug; 15(8):782-90.

View in: PubMed
Yalcindag A, Sundel R. Vasculitis in childhood. Curr Opin Rheumatol. 2001 Sep; 13(5):422-7.

View in: PubMed
Roy-Bornstein C, Sagor LD, Roberts KB. Treatment of a Jehovah's Witness with immune globulin: case of a child with Kawasaki syndrome. Pediatrics. 1994 Jul; 94(1):112-3.

View in: PubMed

People

Explore

Similar Concepts

Top Journals